GeneWeave Biosciences, Inc.

GeneWeave Biosciences, Inc., is a medical diagnostics company focused on infectious diseases. GeneWeave was acquired by Roche Holding AG in 2015.

Acuamark Diagnostics, Inc.

Acuamark Diagnostics is developing novel diagnostic tests to enable low-cost and accurate early detection of colorectal cancer directly from the blood, by isolating and identifying multiple cancer markers. Thus, allowing for improved sensitivity, specificity, and scalability.